Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Rasche

Showing results (81-90 of 170) with videos related to

Pageof 17
Sort By:
The Oncologist|February 12, 2020
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF-MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System InvolvementMatteo Claudio Da Vià, Antonio Giovanni Solimando, Andoni Garitano-Trojaola, et al.
Leukemia|September 29, 2021
Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progressionJulia Dahlhoff, Hannah Manz, Tim Steinfatt, et al.
Blood Cancer Journal|April 8, 2025
Real-world treatment patterns for teclistamab and talquetamab in multiple myeloma (MM): experience from 609 patientsFarheen Chunara, Chris Lugo, Kristen Osinski, et al.
Annals of Hematology|April 11, 2023
Gut microbiome alterations in patients with COVID-19-related coagulopathyYouli Chen, Xin Li, Cheng Yu, et al.
Haematologica|December 1, 2020
Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in GermanyMonika Engelhardt, Khalid Shoumariyeh, Amelie Rösner, et al.
Frontiers in Artificial Intelligence|September 20, 2021
Reliable and Interpretable Mortality Prediction With Strong Foresight in COVID-19 Patients: An International Study From China and GermanyTao Bai, Xue Zhu, Xiang Zhou, et al.
British Journal of Haematology|May 18, 2022
Minimal residual disease and imaging-guided consolidation strategies in newly diagnosed and relapsed refractory multiple myelomaDavid Böckle, Paula Tabares, Xiang Zhou, et al.
Cancers|August 28, 2020
The Link between Cytogenetics/Genomics and Imaging Patterns of Relapse and Progression in Patients with Relapsed/Refractory Multiple Myeloma: A Pilot Study Utilizing 18F-FDG PET/CTXiang Zhou, Alexander Dierks, Olivia Kertels, et al.
Haematologica|February 1, 2023
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cellsEstefanía García-Guerrero, Luis G Rodríguez-Lobato, Belén Sierro-Martínez, et al.
Blood Advances|August 17, 2022
Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell levelCarolina Schinke, Alexandra M Poos, Michael Bauer, et al.
Pageof 17

Showing results (81-90 of 170) with videos related to

Sort By:
Pageof 17
The Oncologist|February 12, 2020
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF-MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System InvolvementMatteo Claudio Da Vià, Antonio Giovanni Solimando, Andoni Garitano-Trojaola, et al.
Leukemia|September 29, 2021
Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progressionJulia Dahlhoff, Hannah Manz, Tim Steinfatt, et al.
Blood Cancer Journal|April 8, 2025
Real-world treatment patterns for teclistamab and talquetamab in multiple myeloma (MM): experience from 609 patientsFarheen Chunara, Chris Lugo, Kristen Osinski, et al.
Annals of Hematology|April 11, 2023
Gut microbiome alterations in patients with COVID-19-related coagulopathyYouli Chen, Xin Li, Cheng Yu, et al.
Haematologica|December 1, 2020
Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in GermanyMonika Engelhardt, Khalid Shoumariyeh, Amelie Rösner, et al.
Frontiers in Artificial Intelligence|September 20, 2021
Reliable and Interpretable Mortality Prediction With Strong Foresight in COVID-19 Patients: An International Study From China and GermanyTao Bai, Xue Zhu, Xiang Zhou, et al.
British Journal of Haematology|May 18, 2022
Minimal residual disease and imaging-guided consolidation strategies in newly diagnosed and relapsed refractory multiple myelomaDavid Böckle, Paula Tabares, Xiang Zhou, et al.
Cancers|August 28, 2020
The Link between Cytogenetics/Genomics and Imaging Patterns of Relapse and Progression in Patients with Relapsed/Refractory Multiple Myeloma: A Pilot Study Utilizing 18F-FDG PET/CTXiang Zhou, Alexander Dierks, Olivia Kertels, et al.
Haematologica|February 1, 2023
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cellsEstefanía García-Guerrero, Luis G Rodríguez-Lobato, Belén Sierro-Martínez, et al.
Blood Advances|August 17, 2022
Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell levelCarolina Schinke, Alexandra M Poos, Michael Bauer, et al.
Pageof 17